Digital technologies for the assessment of cognition: a clinical review A Chinner, J Blane, C Lancaster, C Hinds, I Koychev BMJ Ment Health 21 (2), 67-71, 2018 | 45 | 2018 |
The elusive nature of APOE ε4 in mid-adulthood: Understanding the cognitive profile C Lancaster, N Tabet, J Rusted Journal of the International Neuropsychological Society 23 (3), 239-253, 2017 | 44 | 2017 |
Remote monitoring technologies in Alzheimer’s disease: design of the RADAR-AD study M Muurling, C de Boer, R Kozak, D Religa, I Koychev, H Verheij, ... Alzheimer's research & therapy 13 (1), 89, 2021 | 43 | 2021 |
Evaluating the feasibility of frequent cognitive assessment using the Mezurio smartphone app: observational and interview study in adults with elevated dementia risk C Lancaster, I Koychev, J Blane, A Chinner, L Wolters, C Hinds JMIR mHealth and uHealth 8 (4), e16142, 2020 | 38 | 2020 |
Gallery Game: Smartphone-based assessment of long-term memory in adults at risk of Alzheimer’s disease C Lancaster, I Koychev, J Blane, A Chinner, C Chatham, K Taylor, ... Journal of clinical and experimental neuropsychology 42 (4), 329-343, 2020 | 30 | 2020 |
The APOE paradox: do attentional control differences in mid-adulthood reflect risk of late-life cognitive decline C Lancaster, N Tabet, J Rusted Neurobiology of aging 48, 114-121, 2016 | 25 | 2016 |
Impairment in theory of mind in Parkinson’s disease is explained by deficits in inhibition JA Foley, C Lancaster, E Poznyak, O Borejko, E Niven, T Foltynie, ... Parkinson’s Disease 2019 (1), 5480913, 2019 | 23 | 2019 |
Putting attention in the spotlight: The influence of APOE genotype on visual search in mid adulthood C Lancaster, S Forster, N Tabet, J Rusted Behavioural Brain Research 334, 97-104, 2017 | 23 | 2017 |
Artificial intelligence for dementia—Applied models and digital health DM Lyall, A Kormilitzin, C Lancaster, J Sousa, F Petermann‐Rocha, ... Alzheimer's & Dementia 19 (12), 5872-5884, 2023 | 14 | 2023 |
The Mezurio smartphone application: Evaluating the feasibility of frequent digital cognitive assessment in the PREVENT dementia study C Lancaster, J Blane, A Chinner, L Wolters, I Koychev, C Hinds MedRxiv, 19005124, 2019 | 10 | 2019 |
Prospective memory: Age related change is influenced by APOE genotype C Lancaster, MA McDaniel, N Tabet, J Rusted Aging, Neuropsychology, and Cognition 27 (5), 710-728, 2020 | 6 | 2020 |
TD‐P‐15: GAMECHANGER: CAN DIGITAL BIOMARKERS TRANSFORM THE DETECTION OF PRECLINICAL ALZHEIMER'S DISEASE? CL Lancaster, C Hinds Alzheimer's & Dementia 15, P159-P159, 2019 | 1 | 2019 |
P4‐605: story time: computational analysis of raw‐speech to aid the detection of preclinical Alzheimer's disease A Atreya, CL Lancaster, IG Koychev, A Chinner, J Blane, C Chatham, ... Alzheimer's & Dementia 15, P1556-P1556, 2019 | 1 | 2019 |
P1‐448: GAMECHANGER: CAN DIGITAL BIOMARKERS TRANSFORM THE DETECTION OF PRECLINICAL ALZHEIMER'S DISEASE? CL Lancaster, C Hinds Alzheimer's & Dementia 15, P438-P438, 2019 | 1 | 2019 |
The elusive nature of APOE e4 in mid-adulthood: understanding the cognitive profile C Lancaster, N Tabet, J Rusted University of Sussex, 2016 | 1 | 2016 |
Investigating the interactive effects of Age, APOE, and anti-seizure medication Levetiracetam on executive function in healthy adulthood. C Lancaster, C Bird, J Rusted, N Dowell, N Tabet OSF, 2024 | | 2024 |
Perceptual Discrimination of Complex Objects: Gene-dose effects of APOE e4 in mid-life CL Lancaster, S Berens, J Daly, JM Rusted, C Bird Alzheimer's Association International Conference, 2024 | | 2024 |
Do the effects of Hormone Replacement Therapy during menopause differ by APOE genotype? E Budden, S Atkinson, S Berens, A Stanton, SL King, AM Minihane, ... Alzheimer's Association International Conference, 2024 | | 2024 |
Downregulating functional hyperactivity in APOE ε4 carriers: an important avenue for early‐life risk reduction CL Lancaster, N Dowell, A Bakker, C Hinds, P Nwaubani, C Bird, N Tabet, ... Alzheimer's & Dementia 19, e075656, 2023 | | 2023 |
Early detection of Alzheimer’s disease using smartphone-based active tasks: how well do they scale, and at what disease stage are they effective? C Hinds, CL Lancaster, M Muurling, C de Boer, A Atreya, S Vairavan, ... Alzheimer's Association International Conference, 2023 | | 2023 |